Receptor Activation
Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). It binds to GHRH receptors located in the anterior pituitary, initiating signaling pathways involved in the regulation of endogenous growth hormone release.
Cell Signaling Process
Activation of pituitary GHRH receptors stimulates intracellular cascades that influence pulsatile growth hormone secretion. Downstream signaling includes pathways associated with insulin-like growth factor-1 (IGF-1), which participates in cellular growth-factor communication and metabolic signaling at the molecular level.
Neural Activity (if applicable)
Growth hormone regulation is coordinated through hypothalamic–pituitary neuroendocrine circuits. These central pathways manage rhythmic hormone signaling and feedback mechanisms that maintain endocrine balance.
Autonomic or Regulatory Pathways
Sermorelin interacts with endocrine feedback systems that regulate hormone signaling patterns and receptor responsiveness. Through receptor-mediated activity, it supports structured communication within the growth hormone axis under normal physiological frameworks.